129 related articles for article (PubMed ID: 26358474)
1. Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition-Associated Checkpoint Abrogation.
Mikami K; Medová M; Nisa L; Francica P; Glück AA; Tschan MP; Blaukat A; Bladt F; Aebersold DM; Zimmer Y
Mol Cancer Res; 2015 Dec; 13(12):1544-53. PubMed ID: 26358474
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
Wang Y; Yang L; Zhang J; Zhou M; Shen L; Deng W; Liang L; Hu R; Yang W; Yao Y; Zhang H; Zhang Z
Int J Oncol; 2018 Oct; 53(4):1667-1680. PubMed ID: 30085332
[TBL] [Abstract][Full Text] [Related]
3. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints.
Tao Y; Leteur C; Yang C; Zhang P; Castedo M; Pierré A; Golsteyn RM; Bourhis J; Kroemer G; Deutsch E
Cell Cycle; 2009 Apr; 8(8):1196-205. PubMed ID: 19305158
[TBL] [Abstract][Full Text] [Related]
5. Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1.
Vance S; Liu E; Zhao L; Parsels JD; Parsels LA; Brown JL; Maybaum J; Lawrence TS; Morgan MA
Cell Cycle; 2011 Dec; 10(24):4321-9. PubMed ID: 22134241
[TBL] [Abstract][Full Text] [Related]
6. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
7. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.
Jurvansuu J; Fragkos M; Ingemarsdotter C; Beard P
J Mol Biol; 2007 Sep; 372(2):397-406. PubMed ID: 17663993
[TBL] [Abstract][Full Text] [Related]
8. The interaction between two radiosensitizers: 5-iododeoxyuridine and caffeine.
Seo Y; Yan T; Schupp JE; Yamane K; Radivoyevitch T; Kinsella TJ
Cancer Res; 2006 Jan; 66(1):490-8. PubMed ID: 16397265
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe.
Tse AN; Schwartz GK
Cancer Res; 2004 Sep; 64(18):6635-44. PubMed ID: 15374978
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay.
Powell SN; DeFrank JS; Connell P; Eogan M; Preffer F; Dombkowski D; Tang W; Friend S
Cancer Res; 1995 Apr; 55(8):1643-8. PubMed ID: 7712468
[TBL] [Abstract][Full Text] [Related]
11. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells.
Huaying S; Dong Y; Chihong Z; Xiaoqian Q; Danying W; Jianguo F
Med Sci Monit; 2016 Dec; 22():5041-5048. PubMed ID: 28002389
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.
Wang Y; Li J; Booher RN; Kraker A; Lawrence T; Leopold WR; Sun Y
Cancer Res; 2001 Nov; 61(22):8211-7. PubMed ID: 11719452
[TBL] [Abstract][Full Text] [Related]
14. Targeted radiosensitization by the Chk1 inhibitor SAR-020106.
Borst GR; McLaughlin M; Kyula JN; Neijenhuis S; Khan A; Good J; Zaidi S; Powell NG; Meier P; Collins I; Garrett MD; Verheij M; Harrington KJ
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1110-8. PubMed ID: 22981708
[TBL] [Abstract][Full Text] [Related]
15. Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines.
Russell KJ; Wiens LW; Demers GW; Galloway DA; Le T; Rice GC; Bianco JA; Singer JW; Groudine M
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1099-106. PubMed ID: 8985032
[TBL] [Abstract][Full Text] [Related]
16. HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1.
Busch CJ; Kriegs M; Laban S; Tribius S; Knecht R; Petersen C; Dikomey E; Rieckmann T
Radiother Oncol; 2013 Sep; 108(3):495-9. PubMed ID: 23932155
[TBL] [Abstract][Full Text] [Related]
17. Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells.
Wang Y; Liu Q; Liu Z; Li B; Sun Z; Zhou H; Zhang X; Gong Y; Shao C
Mutat Res; 2012 Jun; 734(1-2):20-9. PubMed ID: 22561209
[TBL] [Abstract][Full Text] [Related]
18. MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.
Bridges KA; Chen X; Liu H; Rock C; Buchholz TA; Shumway SD; Skinner HD; Meyn RE
Oncotarget; 2016 Nov; 7(44):71660-71672. PubMed ID: 27690219
[TBL] [Abstract][Full Text] [Related]
19. Genome wide expression analysis of radiation-induced DNA damage responses in isogenic HCT116 p53+/+ and HCT116 p53-/- colorectal carcinoma cell lines.
Lindgren T; Stigbrand T; Råberg A; Riklund K; Johansson L; Eriksson D
Int J Radiat Biol; 2015 Jan; 91(1):99-111. PubMed ID: 25219679
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.
Hirose Y; Berger MS; Pieper RO
Cancer Res; 2001 Aug; 61(15):5843-9. PubMed ID: 11479224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]